RA Capital Management, L.P. 13D and 13G filings for CytomX Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:11 pm Sale | 2021-12-31 | 13G | CytomX Therapeutics, Inc. CTMX | RA Capital Management, L.P. | 0 0.000% | -3,500,000 (Position Closed) | Filing |
| 2021-01-29 4:30 pm Purchase | 2021-01-29 | 13G | CytomX Therapeutics, Inc. CTMX | RA Capital Management, L.P. | 3,500,000 5.800% | 3,500,000 (New Position) | Filing |